Emergence of an early SARS-CoV-2 epidemic in the United States

Mark Zeller , Karthik Gangavarapu , Catelyn Anderson , Allison R Smither
Cell 184 ( 19) 4939 -4952. e15

42
2021
Emergence of an early SARS-CoV-2 epidemic in the United States (preprint)

Mark Zeller , Karthik Gangavarapu , Catelyn Anderson , Allison R Smither

1
2021
Loss of apolipoprotein B100 decreases viral infectivity and depletes cholesterol from HCV virions: 1487

Esperance A Schaefer , James Meixiong , Daniel Motola , Amy Deik
Hepatology 58 929A -929A

2013
HMG-CoA Reductase Inhibition Alters the Lipidome and Infectious Properties of HCV Virus Particles: 1503

Lee F Peng , James Meixiong , Amy Deik , Esperance A Schaefer
Hepatology 58 936A -936A

2013
The anti-HCV effector genes SART1 and EFTUD2 regulate IFN stimulated genes through a nonclassical mechanism: 1023

Wenyu Lin , Lei Zhao , Du Cheng , Pattranuch Chusri
Hepatology 56 686a -686a

2
2012
HIV/HCV in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types

Shadi Salloum , Jacinta A Holmes , Rohit Jindal , Shyam S Bale
Hepatology (Baltimore, Md.) 64 ( 6) 1951 -1951

1
2016
Real World Experience with Sofosbuvir and Simeprevir combination treatment in patients with HCV genotype 1: 995

Ming V Lin , Neliswa A Gogela , Jessica L Wisocky , Michael Thiim
Hepatology 60 683A -684A

1
2014
Role of the PDIPI protein in the IFN response during hepatitis C virus infection: impact of PPAR nuclear receptors: 1490

Stephane Chevaliez , Cynthia Brisac , Esperance A Schaefer , Daniel Wombua
Hepatology 58 930A -930A

2013
EFTUD2 regulates hepatitis C virus replication through the RIG-I/MDA5 pathway: 197

Chuanlong Zhu , Jian Hong , Lei Zhao , Pattranuch Chusri
Hepatology 58 306A -306A

2013
The anti-HCV gene SART1 regulates IFN stimulated genes through nonclassical mechanisms: 240

Wenyu Lin , Chuanlong Zhu , Jian Hong , Lei Zhao
Hepatology 58 327A -328A

2013
HCV induces hepatocyte TGF-β1 release through activation of ER Stress and the unfolded protein response: 1260

Pattranuch Chusri , Du Cheng , Nikolaus Jilg , Dahlene N Fusco
Hepatology 56 790A -791A

2012
Apolipoprotein B 100 is critical for HCV infection and for the pro-viral effects of microRNA-122 in vitro: 59

Esperance A Schaefer , Daniel Motola , Carol Lin , James Meixiong
Hepatology 56 221A -221A

2012
CHI3L1 reciprocally promotes HCV replication and stimulates hepatocyte profibrogenic cytokine release: 1047

Du Cheng , Wenyu Lin , Esperance A Schaefer , Nikolaus Jilg
Hepatology 56 697a -697a

2012
Identification of Interferon Effector Genes as New Targets for HCV Antiviral Development: 1031

Dahlene N Fusco , Cynthia Brisac , Yi-Wen Huang , Tiao Xie
Hepatology 56 690a -690a

2012
HIV AND HCV COOPERATIVELY INDUCE HEPATIC FIBROGENESIS IN HEPATOCYTE-HEPATIC STELLATE CELL COCULTURES MODEL: 833

Wenyu Lin , Kattareeya Kumthip , Guoyang Wu , Du Cheng
Hepatology 54 ( 4) 753A -753A

2011
HCV NS5A DISRUPTED STAT1 PHOSPHORYLATION AND ASSOCIATED WITH SUPPRESSION OF IFN SIGNALING: 95

Kattareeya Kumthip , Niwat Maneekarn , Amornrat O'Brien , Satawat Thongsawat
Hepatology 54 ( 4) 406A -407A

2011
APOLIPOPROTEIN B-100 PROMOTES HCV REPLICATION AND PARTIALLY MEDIATES THE PROVIRAL EFFECTS OF MICRORNA122: 2091

Esperance A Schaefer , Nikolaus Jilg , Kattareeya Kumthip , Dahlene N Fusco
Hepatology 54 ( 4) 1341A -1341A

2011
HCV STIMULATES HEPATIC FIBROGENESIS THROUGH INCREASING CHI3L1 EXPRESSION: 2078

Du Cheng , Wenyu Lin , Victoria Llado , Kattareeya Kumthip
Hepatology 54 ( 4) 1335A -1335A

2011